T8	Exp 20 57	the human immunodeficiency virus type
T9	Exp 91 119	the human T-cell line Jurkat
T10	Exp 233 237	that
T11	Exp 122 139	The transcription
T12	Exp 143 180	the human immunodeficiency virus type
T13	Exp 200 211	the control
T14	Exp 246 276	the viral long terminal repeat
T15	Exp 290 317	the protein-binding regions
T16	Exp 321 330	the HIV-1
T17	Exp 338 371	the transcription-enhancer region
T18	Exp 373 375	We
T19	Exp 381 385	that
T20	Exp 460 476	the HIV enhancer
T21	Exp 549 553	they
T22	Exp 521 541	their surface charge
T23	Exp 494 510	The two proteins
T24	Exp 663 676	their binding
T25	Exp 697 702	which
T26	Exp 711 734	the HIV-enhancer domain
T27	Exp 801 850	the interleukin-2-receptor alpha-subunit enhancer
T28	Exp 852 876	The inducible C1 protein
R5	Coref Anaphora:T10 Antecedent:T29
R6	Coref Anaphora:T22 Antecedent:T23
R7	Coref Anaphora:T21 Antecedent:T23
R8	Coref Anaphora:T24 Antecedent:T30
R9	Coref Anaphora:T25 Antecedent:T31
T1	Protein 410 412	C1
T2	Protein 436 438	C2
T3	Protein 741 743	C1
T4	Protein 748 750	C2
T5	Protein 805 841	interleukin-2-receptor alpha-subunit
T6	Protein 866 868	C1
T29	Exp 215 232	cellular proteins
T30	Exp 602 618	Bivalent cations
T31	Exp 680 696	oligonucleotides
